164 related articles for article (PubMed ID: 14638475)
1. In vivo selection of a chromosomally encoded beta-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca.
Mammeri H; Poirel L; Nordmann P
Antimicrob Agents Chemother; 2003 Dec; 47(12):3739-42. PubMed ID: 14638475
[TBL] [Abstract][Full Text] [Related]
2. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity.
Nijhuis RH; Oueslati S; Zhou K; Bosboom RW; Rossen JW; Naas T
J Antimicrob Chemother; 2015 May; 70(5):1429-33. PubMed ID: 25630648
[TBL] [Abstract][Full Text] [Related]
3. Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.
Liu Y; Mee BJ; Mulgrave L
J Clin Microbiol; 1997 Sep; 35(9):2365-9. PubMed ID: 9276417
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
Yigit H; Queenan AM; Rasheed JK; Biddle JW; Domenech-Sanchez A; Alberti S; Bush K; Tenover FC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3881-9. PubMed ID: 14638498
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
[TBL] [Abstract][Full Text] [Related]
7. Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxytoca.
Fevre C; Jbel M; Passet V; Weill FX; Grimont PA; Brisse S
Antimicrob Agents Chemother; 2005 Aug; 49(8):3453-62. PubMed ID: 16048960
[TBL] [Abstract][Full Text] [Related]
8. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
Chen LR; Zhou HW; Cai JC; Zhang R; Chen GX
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):163-7. PubMed ID: 19748427
[TBL] [Abstract][Full Text] [Related]
9. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
[TBL] [Abstract][Full Text] [Related]
10. New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3).
Granier SA; Leflon-Guibout V; Goldstein FW; Nicolas-Chanoine MH
Antimicrob Agents Chemother; 2003 Sep; 47(9):2922-8. PubMed ID: 12936995
[TBL] [Abstract][Full Text] [Related]
11. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.
Izdebski R; Fiett J; Urbanowicz P; Baraniak A; Derde LP; Bonten MJ; Carmeli Y; Goossens H; Hryniewicz W; Brun-Buisson C; Brisse S; Gniadkowski M; ;
J Antimicrob Chemother; 2015 Dec; 70(12):3230-7. PubMed ID: 26318191
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
Fujita A; Kimura K; Yokoyama S; Jin W; Wachino J; Yamada K; Suematsu H; Yamagishi Y; Mikamo H; Arakawa Y
PLoS One; 2015; 10(11):e0142366. PubMed ID: 26539828
[TBL] [Abstract][Full Text] [Related]
13. Ceftazidime-resistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland.
Rodríguez-Martínez JM; Poirel L; Nordmann P; Fankhauser C; Francois P; Schrenzel J
Int J Antimicrob Agents; 2008 Sep; 32(3):278-9. PubMed ID: 18602252
[No Abstract] [Full Text] [Related]
14. First report of a novel extended-spectrum beta-lactamase KOXY-2 producing Klebsiella oxytoca that hydrolyses cefotaxime and ceftazidime.
Younes A; Hamouda A; Amyes SG
J Chemother; 2011 Jun; 23(3):127-30. PubMed ID: 21742579
[TBL] [Abstract][Full Text] [Related]
15. Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.
Payne DJ; Marriott MS; Amyes SG
J Antimicrob Chemother; 1989 Aug; 24(2):103-10. PubMed ID: 2676935
[TBL] [Abstract][Full Text] [Related]
16. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
[TBL] [Abstract][Full Text] [Related]
17. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases and strains with extended-spectrum activity of the chromosomal beta-lactamase.
Decré D; Burghoffer B; Gautier V; Petit JC; Arlet G
J Antimicrob Chemother; 2004 Nov; 54(5):881-8. PubMed ID: 15472005
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
Hibbert-Rogers LC; Heritage J; Gascoyne-Binzi DM; Hawkey PM; Todd N; Lewis IJ; Bailey C
J Antimicrob Chemother; 1995 Jul; 36(1):65-82. PubMed ID: 8537285
[TBL] [Abstract][Full Text] [Related]
19. Overproduction of K1 enzyme in Klebsiella oxytoca clinical isolates against ceftazidime, cefepime and ceftobiprole.
Corvec S; Cremet L; Lepelletier D; Reynaud A; Drugeon H
J Chemother; 2009 Jun; 21(3):365-6. PubMed ID: 19567362
[No Abstract] [Full Text] [Related]
20. Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.
Pérez-Llarena FJ; Fernández A; Zamorano L; Kerff F; Beceiro A; Aracil B; Cercenado E; Miro E; Oliver A; Oteo J; Navarro F; Bou G
Antimicrob Agents Chemother; 2012 Aug; 56(8):4540-3. PubMed ID: 22668859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
